Abortion pill ruling sparks condemnation from experts and drug company leaders.

Experts say U.S. District Judge Matthew Kacsmaryk's decision to put the FDA's approval of the abortion drug mifepristone on hold is unprecedented and ideological, using politicized terminology and endorsing the contentious idea of "fetal personhood." Kacsmaryk's ruling has thrown future access to medication abortion into question nationwide and laid the foundation for a high-stakes Supreme Court battle. The ruling is set to go into effect at the end of this week unless a higher court intervenes.